tiprankstipranks
Suven Pharmaceuticals Ltd. (IN:COHANCE)
:COHANCE
India Market
COHANCE
Suven Pharmaceuticals Ltd.
RESEARCH TOOLSreports
Want to see IN:COHANCE full AI Analyst Report?

Suven Pharmaceuticals Ltd. (COHANCE) Ratios

2 Followers

Suven Pharmaceuticals Ltd. Ratios

IN:COHANCE's free cash flow for Q2 2026 was ₹0.75. For the 2026 fiscal year, IN:COHANCE's free cash flow was decreased by ₹ and operating cash flow was ₹0.17. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 2.78 2.78 2.43 11.82 6.37
Quick Ratio
 1.91 1.91 1.98 9.65 4.40
Cash Ratio
 0.09 0.09 0.23 0.44 0.41
Solvency Ratio
 0.20 0.22 0.29 1.74 1.99
Operating Cash Flow Ratio
 0.40 0.55 0.79 3.35 2.84
Short-Term Operating Cash Flow Coverage
 1.81 2.46 4.01 9.29 6.98
Net Current Asset Value
₹ 1.00B₹ 1.00B₹ -3.03B₹ 10.60B₹ 7.80B
Leverage Ratios
Debt-to-Assets Ratio
 0.07 0.07 0.09 0.03 0.04
Debt-to-Equity Ratio
 0.10 0.10 0.16 0.03 0.04
Debt-to-Capital Ratio
 0.09 0.09 0.14 0.03 0.04
Long-Term Debt-to-Capital Ratio
 0.01 0.01 <0.01 0.00 <0.01
Financial Leverage Ratio
 1.46 1.46 1.79 1.10 1.13
Debt Service Coverage Ratio
 1.99 2.04 3.87 7.87 6.10
Interest Coverage Ratio
 11.83 6.44 45.80 61.84 40.50
Debt to Market Cap
 0.01 0.02 <0.01 <0.01 <0.01
Interest Debt Per Share
 11.42 11.45 11.36 2.85 3.27
Net Debt to EBITDA
 0.82 0.80 0.48 0.04 <0.01
Profitability Margins
Gross Profit Margin
62.85%40.15%68.63%57.34%56.32%
EBIT Margin
11.31%10.56%27.40%39.29%42.72%
EBITDA Margin
18.43%18.82%33.87%44.49%46.28%
Operating Profit Margin
19.42%10.56%47.23%43.83%38.71%
Pretax Profit Margin
9.13%9.13%28.72%38.59%41.76%
Net Profit Margin
7.90%7.90%22.37%28.56%30.69%
Continuous Operations Profit Margin
6.62%6.62%22.11%28.56%30.69%
Net Income Per EBT
86.57%86.57%77.89%74.02%73.48%
EBT Per EBIT
46.99%86.39%60.80%88.04%107.89%
Return on Assets (ROA)
3.13%3.13%8.84%13.32%20.92%
Return on Equity (ROE)
6.38%4.58%15.79%14.64%23.70%
Return on Capital Employed (ROCE)
8.67%4.71%21.21%21.46%28.71%
Return on Invested Capital (ROIC)
6.11%3.32%15.72%15.57%20.36%
Return on Tangible Assets
4.12%4.12%11.58%13.70%21.61%
Earnings Yield
1.12%1.56%0.97%1.76%3.42%
Efficiency Ratios
Receivables Turnover
 3.29 3.29 4.20 7.87 12.08
Payables Turnover
 2.96 4.77 4.68 10.59 12.00
Inventory Turnover
 1.50 2.41 2.26 1.94 1.87
Fixed Asset Turnover
 1.05 1.05 0.96 1.34 1.75
Asset Turnover
 0.40 0.40 0.40 0.47 0.68
Working Capital Turnover Ratio
 1.92 2.71 1.43 1.05 1.51
Cash Conversion Cycle
 231.09 185.50 170.71 200.08 194.83
Days of Sales Outstanding
 110.85 110.85 86.81 46.40 30.21
Days of Inventory Outstanding
 243.48 151.15 161.82 188.15 195.03
Days of Payables Outstanding
 123.24 76.51 77.92 34.47 30.41
Operating Cycle
 354.33 262.01 248.63 234.55 225.24
Cash Flow Ratios
Operating Cash Flow Per Share
 6.81 9.29 11.24 14.09 17.71
Free Cash Flow Per Share
 4.47 3.53 5.16 12.05 6.49
CapEx Per Share
 2.34 5.75 6.07 2.04 11.23
Free Cash Flow to Operating Cash Flow
 0.66 0.38 0.46 0.86 0.37
Dividend Paid and CapEx Coverage Ratio
 2.91 1.61 1.85 6.92 0.92
Capital Expenditure Coverage Ratio
 2.91 1.61 1.85 6.92 1.58
Operating Cash Flow Coverage Ratio
 0.65 0.89 1.03 5.52 6.41
Operating Cash Flow to Sales Ratio
 0.12 0.16 0.24 0.34 0.34
Free Cash Flow Yield
1.07%1.17%0.48%1.80%1.37%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 89.52 64.28 102.82 56.75 29.24
Price-to-Sales (P/S) Ratio
 7.06 5.08 23.00 16.21 8.97
Price-to-Book (P/B) Ratio
 4.10 2.95 16.23 8.31 6.93
Price-to-Free Cash Flow (P/FCF) Ratio
 93.40 85.28 207.95 55.57 72.82
Price-to-Operating Cash Flow Ratio
 61.44 32.45 95.58 47.54 26.67
Price-to-Earnings Growth (PEG) Ratio
 -2.50 -1.16 -9.48 -2.10 -3.12
Price-to-Fair Value
 4.10 2.95 16.23 8.31 6.93
Enterprise Value Multiple
 39.11 27.78 68.39 36.47 19.40
Enterprise Value
 163.53B 118.61B 277.37B 170.60B 120.31B
EV to EBITDA
 39.11 27.78 68.39 36.47 19.40
EV to Sales
 7.21 5.23 23.16 16.23 8.98
EV to Free Cash Flow
 95.39 87.80 209.42 55.62 72.85
EV to Operating Cash Flow
 62.62 33.41 96.26 47.59 26.68
Tangible Book Value Per Share
 69.15 69.36 43.74 78.15 65.72
Shareholders’ Equity Per Share
 102.03 102.35 66.16 80.58 68.16
Tax and Other Ratios
Effective Tax Rate
 0.27 0.27 0.23 0.26 0.27
Revenue Per Share
 59.18 59.36 46.70 41.31 52.65
Net Income Per Share
 4.68 4.69 10.45 11.80 16.16
Tax Burden
 0.87 0.87 0.78 0.74 0.73
Interest Burden
 0.81 0.86 1.05 0.98 0.98
Research & Development to Revenue
 0.00 0.00 0.00 0.00 <0.01
SG&A to Revenue
 0.14 0.30 0.21 0.13 0.01
Stock-Based Compensation to Revenue
 <0.01 0.00 0.01 <0.01 0.00
Income Quality
 0.88 1.98 0.84 1.19 0.81
Currency in INR